Riskpilot← Back to searchSign inGet full accessBRYNEKLINIKKEN AS
ASActiveOrg 923395881Jernbanegata 5, 4340 BrynePhysiotherapy activities · NACE 8695Est. 20192 employees
Revenue 2025
NOK 20K
-95% vs 2024
EBITDA margin
-141.8%
-192% vs 2024
Equity ratio
14.8%
Financial strength
Net profit 2025
NOK -29K
-296% vs 2024
| Revenue | NOK 20K | -95% |
| EBITDA | NOK -29K | -192% |
| Net profit | NOK -29K | -296% |
| Total assets | NOK 62K | -32% |
| Equity | NOK 9K | +101% |
| Employees | 2 | — |
Legal name
BRYNEKLINIKKEN AS
Org number
923395881
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
13. september 2019
Share capital
NOK 680 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Fysioterapitjenester og naprapatbehandlinger og andre helsefremmende tjenester/ produkter som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Jernbanegata 5, 4340 Bryne
Phone
+4794076238
Email
marthe@bryneklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 433 | 310 | 512 | 401 | 20 |
| Staff expenses | −154 | −179 | −511 | −348 | −0 |
| EBITDA | −5 | −154 | −107 | 31 | −29 |
| Depreciation & amort. | −23 | −23 | −23 | −16 | −0 |
| EBIT | −28 | −176 | −130 | 14 | −29 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −28 | −176 | −130 | 15 | −29 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −28 | −176 | −130 | 15 | −29 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 218 | 76 | 60 | 91 | 62 |
| Equity | −321 | −497 | −627 | −612 | 9 |
| Long-term debt | 180 | 180 | 180 | 180 | 0 |
| Short-term debt | 359 | 393 | 507 | 523 | 23 |
| Total debt | 539 | 573 | 687 | 703 | 53 |
EBITDA margin
-141.8%
This company
15.8%
Market median
-997% vs market
20212025
Equity ratio
14.8%
This company
38.2%
Market median
-61% vs market
20212025
Return on equity
-311.5%
This company
18.4%
Market median
-1793% vs market
20212025
Net profit margin
-141.6%
This company
8.1%
Market median
-1848% vs market
20212025
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20212025
Debt / equity
5.74×
This company
0.62×
Market median
-826% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ÅU Chief Executive Officer | Chief Executive Officer | 2019 |
FU Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BRYNEKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ådne Underhaug | Chief Executive Officer | 0 companies |
| Finn Underhaug | Chief Executive Officer | 0 companies |
| Marthe Aalerud | Chairman | 0 companies |